Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Dow
Johnson and Johnson
Baxter
Boehringer Ingelheim
Colorcon
Mallinckrodt

Last Updated: October 16, 2019

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR NORDITROPIN

See Plans and Pricing

« Back to Dashboard

Clinical Trials for Norditropin

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00102817 Somatropin (Norditropin) in Insulin-like Growth Factor (IGF) Deficient Children Completed Novo Nordisk A/S Phase 3 2003-05-01 This trial is conducted in the United States of America (USA). This is a 12 month study to determine if Norditropin is safe and effective in children with IGF deficiency.
NCT00184652 Growth Hormone Treatment in Adult Patients With Chronic Kidney Disease Completed Novo Nordisk A/S Phase 2 2003-04-01 This trial is conducted in Asia, Europe, and Middle East. Adult patients with chronic kidney disease are treated with growth hormone to assess effect on nutritional status.
NCT00184678 Effect of Growth Hormone on Bone Mineral Density in Young Adults With Child-hood Onset Growth Hormone Deficiency Completed Novo Nordisk A/S Phase 3 2002-02-01 This trial is conducted in Europe. Growth Hormone in young adults with growth hormone deficiency in childhood. This trial compares a treated group of patients with an untreated group of patients.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Norditropin

Condition Name

Condition Name for Norditropin
Intervention Trials
Growth Hormone Disorder 25
Genetic Disorder 13
Adult Growth Hormone Deficiency 12
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Norditropin
Intervention Trials
Dwarfism, Pituitary 26
Endocrine System Diseases 16
Syndrome 9
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Norditropin

Trials by Country

Trials by Country for Norditropin
Location Trials
United States 83
France 11
Germany 11
Sweden 10
Denmark 9
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Norditropin
Location Trials
New York 6
Pennsylvania 5
Ohio 5
California 5
Washington 5
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Norditropin

Clinical Trial Phase

Clinical Trial Phase for Norditropin
Clinical Trial Phase Trials
Phase 4 3
Phase 3 13
Phase 2/Phase 3 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Norditropin
Clinical Trial Phase Trials
Completed 36
Enrolling by invitation 3
Active, not recruiting 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Norditropin

Sponsor Name

Sponsor Name for Norditropin
Sponsor Trials
Novo Nordisk A/S 47
Johns Hopkins University 2
Duke University 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Norditropin
Sponsor Trials
Industry 47
Other 14
NIH 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Moodys
Boehringer Ingelheim
Colorcon
Express Scripts
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.